Trials / Conditions / Third-generation TKI
Third-generation TKI
3 registered clinical trials studyying Third-generation TKI.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Almonertinib Plus Metronomic Oral Vinorelbine NCT05663177 | Fujian Cancer Hospital | — |
| Withdrawn | Prophylactic HQP1351 Therapy Post-transplants on Leukemia After Allo-HSCT NCT05604755 | xuna | Phase 2 |
| Completed | Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC NCT06613633 | Fudan University | — |